Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Fatal diffuse alveolar damage in two lung transplant patients treated with cetuximab.

Leard LE, Cho BK, Jones KD, Hays SR, Tope WD, Golden JA, Hoopes CW.

J Heart Lung Transplant. 2007 Dec;26(12):1340-4.

PMID:
18096489
2.

Treatment of advanced cutaneous squamous cell carcinomas with epidermal growth factor receptor inhibitors.

Alter M, Satzger I, Mattern A, Kapp A, Gutzmer R.

Dermatology. 2013;227(4):289-94. doi: 10.1159/000355181. Epub 2013 Nov 7. Review.

PMID:
24217470
3.

The role of cetuximab in the treatment of squamous cell cancer of the head and neck.

Burtness B.

Expert Opin Biol Ther. 2005 Aug;5(8):1085-93. Review.

PMID:
16050785
4.

Cutaneous squamous cell carcinoma responding serially to single-agent cetuximab.

Suen JK, Bressler L, Shord SS, Warso M, Villano JL.

Anticancer Drugs. 2007 Aug;18(7):827-9.

PMID:
17581306
5.
6.
7.

Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.

Arnold AW, Bruckner-Tuderman L, Zuger C, Itin PH.

Dermatology. 2009;219(1):80-3. doi: 10.1159/000218714. Epub 2009 May 13.

PMID:
19439919
8.

Targeting epidermal growth factor receptor in head and neck cancer: lessons learned from cetuximab.

Moon C, Chae YK, Lee J.

Exp Biol Med (Maywood). 2010 Aug;235(8):907-20. doi: 10.1258/ebm.2009.009181. Epub 2010 Jun 18. Review.

PMID:
20562132
9.

Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.

Harding J, Burtness B.

Drugs Today (Barc). 2005 Feb;41(2):107-27. Review.

PMID:
15821783
10.

Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.

Uribe P, Gonzalez S.

Pathol Res Pract. 2011 Jun 15;207(6):337-42. doi: 10.1016/j.prp.2011.03.002. Epub 2011 Apr 29. Review.

PMID:
21531084
11.

Cetuximab for treatment of advanced squamous cell carcinoma in solid organ transplant recipients.

Boyd K, Shea SM, Patterson J.

Wien Med Wochenschr. 2013 Aug;163(15-16):372-5. doi: 10.1007/s10354-013-0213-5. Epub 2013 Jun 26. Review.

PMID:
23800851
12.

Treatment of recurrent squamous cell carcinoma of the skin with cetuximab.

Bauman JE, Eaton KD, Martins RG.

Arch Dermatol. 2007 Jul;143(7):889-92.

PMID:
17638733
13.

Cetuximab-associated pulmonary toxicity.

Chua W, Peters M, Loneragan R, Clarke S.

Clin Colorectal Cancer. 2009 Apr;8(2):118-20. doi: 10.3816/CCC.2009.n.019.

PMID:
19739274
14.

Combination of an EGFR blocker and a COX-2 inhibitor for the treatment of advanced cutaneous squamous cell carcinoma.

Jalili A, Pinc A, Pieczkowski F, Karlhofer FM, Stingl G, Wagner SN.

J Dtsch Dermatol Ges. 2008 Dec;6(12):1066-9. doi: 10.1111/j.1610-0387.2008.06861.x. English, German.

PMID:
19138272
15.

A phase II, multicenter study of cetuximab monotherapy in patients with refractory, metastatic colorectal carcinoma with absent epidermal growth factor receptor immunostaining.

Wierzbicki R, Jonker DJ, Moore MJ, Berry SR, Loehrer PJ, Youssoufian H, Rowinsky EK.

Invest New Drugs. 2011 Feb;29(1):167-74. doi: 10.1007/s10637-009-9341-6. Epub 2009 Oct 15.

PMID:
19830388
16.

Association of epidermal growth factor receptor polymorphism, skin toxicity, and outcome in patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment.

Klinghammer K, Knödler M, Schmittel A, Budach V, Keilholz U, Tinhofer I.

Clin Cancer Res. 2010 Jan 1;16(1):304-10. doi: 10.1158/1078-0432.CCR-09-1928. Epub 2009 Dec 22.

17.

The emerging role of cetuximab in head and neck cancer: a 2007 perspective.

Panikkar RP, Astsaturov I, Langer CJ.

Cancer Invest. 2008 Feb;26(1):96-103. doi: 10.1080/07357900701601002. Review.

PMID:
18181051
18.

EGFR-targeting monoclonal antibodies in head and neck cancer.

Astsaturov I, Cohen RB, Harari P.

Curr Cancer Drug Targets. 2007 Nov;7(7):650-65. Review.

PMID:
18045070
19.

Combined cetuximab and genistein treatment shows additive anti-cancer effect on oral squamous cell carcinoma.

Park SJ, Kim MJ, Kim YK, Kim SM, Park JY, Myoung H.

Cancer Lett. 2010 Jun 1;292(1):54-63. doi: 10.1016/j.canlet.2009.11.004. Epub 2009 Dec 2.

PMID:
19959278
20.

Cicatricial ectropion associated with treatment of metastatic colorectal cancer with cetuximab.

Garibaldi DC, Adler RA.

Ophthal Plast Reconstr Surg. 2007 Jan-Feb;23(1):62-3.

PMID:
17237696

Supplemental Content

Support Center